Tizanidine
Product Images NDC 10544-576
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 10544-576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-1 (Image 02)
This appears to be a schedule or timeline related to a medication or drug trial. The numbers on the left (T2, 14, 16, 18) may be related to specific time points or dosages. The text "Hours from Dosing" suggests that the schedule is related to how long after taking the medication certain actions or measurements are taken. However, without additional context it is difficult to determine the specific meaning of this information.*
Post-dose (Image 03)
Ashworth-score (Image 04)
Label Graphic- Tizanidine (apotex) 4mg 30s (Image 05)
This is information about a medication called Tizanidine in the form of Tablets, USP with a strength of 4mg. The medication is only available with a prescription. The tablets should be stored at a controlled room temperature of 20°-25°C (68°-77°F) in a tightly closed, light-resistant container, and away from the reach of children. The base of Tizanidine contains Mig' Apotex Corp and it was packed by Blenheim Pharmacal Inc. There are different lots and expiration dates provided for the tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.